D.E. Shaw & Co’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

D.E. Shaw & Co’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-45,094	Closed	-$554K	–	5163
2022 Q4	$554K	Sell	45,094 -132,681	-75%	-$3.16M	﹤0.01%	3801
2022 Q3	$5.83M	Buy	177,775 +160,243	+914%	+$4.53M	0.01%	1915
2022 Q2	$330K	Sell	17,532 -17,424	-50%	-$334K	﹤0.01%	4312
2022 Q1	$613K	Buy	+34,956	New	+$717K	﹤0.01%	4242

D.E. Shaw & Co's CINC Position: Q1 2023 in Review

D.E. Shaw & Co sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 45,094 shares — an estimated $554K sold.

D.E. Shaw & Co first reported a position in CINC in Q1 2022 and held it in 4 quarters. The position peaked at $5.83M in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

D.E. Shaw & Co reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
D.E. Shaw & Co sold 45,094 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $554K.
D.E. Shaw & Co first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
D.E. Shaw & Co's CinCor Pharma, Inc. Common Stock position peaked at $5.83M in Q3 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.